Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award | 13387

Assoc Prof Dr. Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award 

Assoc Prof Dr. Isabel Rodríguez Sánchez, Clínico San Carlos University Hospital, Spain

Assoc. Prof. Dr. Isabel Rodríguez Sánchez is a specialist in Geriatrics at Clínico San Carlos University Hospital in Madrid, Spain. She holds a PhD in Epidemiology and Public Health and serves as an associate professor at the Complutense University of Madrid. Her research focuses on frailty, chronic disease, and functional impairment in older adults, with over 25 scientific publications, many in high-impact journals. Dr. Rodríguez Sánchez also contributes to national health policy as a member of the Spanish Agency for Medicines and Medical Devices.

Profile

Orcid

🎓 Early Academic Pursuits

Assoc. Prof. Dr. Isabel Rodríguez Sánchez began her academic journey with a strong foundation in medicine, graduating from the Universidad Complutense de Madrid in 2014. Her passion for improving the lives of older adults through evidence-based medical practice guided her specialization in Geriatrics, a field she pursued through rigorous training at the Hospital Universitario La Paz, one of Spain’s most reputable institutions for medical education. Her commitment to research and academic excellence was further solidified with the completion of a PhD in Epidemiology and Public Health from the Universidad Autónoma de Madrid in 2021. Her doctoral thesis, “Dolor crónico, deterioro funcional y enfermedad cardiovascular en las personas mayores,” earned the highest distinction: Cum Laude with an Extraordinary Doctorate Award.

🩺 Professional Endeavors

Dr. Rodríguez Sánchez has accumulated a wealth of clinical experience across several prestigious Spanish institutions. She began her medical career as a Médico Interno Residente (MIR) in Geriatrics from 2015 to 2019 at Hospital Universitario La Paz. This formative period laid the groundwork for her deep understanding of aging, frailty, and complex chronic conditions in older adults.

From 2019 to 2020, she worked as a Geriatrics Specialist at the Hospital de Navarra and concurrently served as a Clinical Associate Professor at the University of Navarra, mentoring young medical students in geriatric medicine. Since 2020, she has held the position of Facultativo Especialista de Área (Consultant Geriatrician) at the Hospital Clínico San Carlos in Madrid, one of Spain’s leading academic hospitals.

In addition to her clinical roles, she was appointed as a Member of the Committee for the Safety of Medicines for Human Use at the Spanish Agency of Medicines and Medical Devices (AEMPS) in 2024, demonstrating her engagement with national health governance and patient safety.

🔬 Contributions and Research Focus

Dr. Rodríguez Sánchez’s research has made significant contributions to the field of aging, particularly in the study of frailty, sarcopenia, chronic diseases, and functional impairment. She has authored or co-authored 25 scientific publications, with 13 published in top-tier Q1 journals, and accumulated over 1300 citations.

Her most notable work includes studies on functional decline following COVID-19 hospitalization in the elderly, multimorbidity in older adults, and the integration of technology for assessing pain and sarcopenia. She is also a co-author of seven book chapters, both in Spanish and international publications, further solidifying her expertise in Geriatrics.

Her research is interdisciplinary, often incorporating biomarkers, imaging (e.g., ultrasound for muscle mass), and digital health tools to enhance diagnosis, prevention, and treatment of geriatric syndromes.

🏅 Accolades and Recognition

Dr. Rodríguez Sánchez has earned numerous awards and recognitions that underscore her contributions to geriatric medicine. In 2022, she received the “Best Abstract – ECGI Category (Early-Career Geriatricians Initiative) Stefania Maggi Award” at the European Geriatric Medicine Society Congress in London. Her award-winning study focused on functional impairment in individuals aged 80+ following COVID-19 hospitalization—a prospective study that she both designed and led.

She has also been invited to serve as a peer reviewer for high-impact international journals, such as Aging Research Reviews, Frontiers, Environmental Research, and the Journal of the American Medical Directors Association, reflecting her respected position in the global research community.

🌍 Impact and Influence

Beyond her publications, Dr. Rodríguez Sánchez actively influences healthcare practice and policy through project evaluations for national and international research funding bodies. Her involvement ensures that projects related to frailty, sarcopenia, post-stroke balance evaluation, and chronic pain management using technological solutions are rigorously assessed and guided by clinical relevance and scientific rigor.

Her dual roles in both clinical practice and academic teaching—as a professor at the Complutense University of Madrid since 2022—enable her to shape the next generation of healthcare professionals. She teaches across multiple programs, including Medicine, Nutrition, and the Master’s in Nutrigenetics, promoting an integrated approach to geriatric care.

🌟 Legacy and Future Contributions

Assoc. Prof. Dr. Isabel Rodríguez Sánchez stands out as a dynamic physician-researcher whose work bridges the gap between science, clinical care, and policy. Her dedication to improving health outcomes for older adults, especially the most vulnerable, positions her as a future leader in geriatric innovation.

Looking forward, she is expected to continue advancing multidimensional assessment tools, precision interventions for frailty and sarcopenia, and policy-oriented research that influences national and European standards of care for the elderly.

Her legacy is being built not only on her academic achievements and clinical expertise but also on her role as a mentor, educator, and advocate for dignified and effective aging care. 🌱

Publication Top Notes

ContributorsIsabel Rodriguez; Jose Antonio Carnicero; Alejandro Álvarez-Bustos; Francisco José García-García; Leocadio Rodríguez-Mañas; Helio
Coelho-Junior
Journal: Nutrients
Year: 2025

Research on Frailty: Where We Stand and Where We Need to Go

ContributorsRodríguez-Mañas, L.; Rodriguez-Sánchez, I.
Journal: American Medical Directors Association
Year: 2021
ContributorsBani Hassan, E.; Phu, S.; Vogrin, S.; Escobedo Terrones, G.; Pérez, X.; Rodriguez-Sanchez, I.; Duque, G.
Journal: Calcified Tissue International
Year: 2019

 

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease